Phosphagenics has released a new Investor Fact Sheet (dated October 2016) on its website. It reads well, imo.
Two points of note – firstly, it seems that the two unidentified products being investigated with Terumo are a gel and a spray.
Secondly, in the section on Production and Personal Care it states that POH has a global distribution agreement with Ashland, supplying TPM and Vital ET as a raw ingredient to multiple commercial partners. In a separate table it refers to Vital-ET based products being currently marketed by Ashland as well as TPM based products partnered with Le Metier + multiple others. ???
http://www.phosphagenics.com/wp-content/uploads/2016/10/Investor-Fact-Sheet-3-Oct-2016.pdf
New Investor Fact Sheet
Add AVE (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
0.3¢ |
Change
0.000(0.00%) |
Mkt cap ! $9.507M | |||
| Open | High | Low | Value | Volume |
| 0.3¢ | 0.3¢ | 0.3¢ | $1.32K | 440K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 30 | 40522233 | 0.2¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.3¢ | 40065430 | 31 |
View Market Depth
| Last trade - 14.05pm 15/11/2024 (20 minute delay) ? |
| AVE (ASX) Chart |